Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?
Leuk Lymphoma
.
2014 Dec;55(12):2675-7.
doi: 10.3109/10428194.2014.918971.
Epub 2014 Jun 27.
Authors
Elizabeth A Brem
1
,
Matthew S Davids
Affiliation
1
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center , Boston, MA , USA.
PMID:
24794805
DOI:
10.3109/10428194.2014.918971
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Lymphoma, Follicular / drug therapy*